“Global Trypsin Market to reach a market value of USD 130.1 Million by 2031 growing at a CAGR of 5.2%”
The Global Trypsin Market size is expected to reach $130.1 million by 2031, rising at a market growth of 5.2% CAGR during the forecast period.
Trypsin’s proteolytic activity makes it effective for exfoliating and renewing the skin. Enzymatic exfoliation with trypsin removes dead skin cells, unclogs pores, and promotes cell turnover, resulting in smoother, brighter, and more youthful-looking skin. Thus, the cosmetics and personal care segment attained 13.4% revenue share in the market 2023. Cosmetics and personal care products, such as facial scrubs, masks, and peels, may incorporate trypsin as a key ingredient for gentle and effective exfoliation.
The expansion of biopharmaceutical manufacturing has led to a higher consumption of trypsin. As biopharmaceutical companies scale up production, particularly for therapeutic proteins, vaccines, and biosimilars, the demand for trypsin, essential in cell culture and protein processing, has surged.
Additionally, chronic diseases such as diabetes, cancer, and inflammatory conditions often require treatments that include proteolytic enzymes like trypsin. Trypsin is used in various therapeutic formulations for its anti-inflammatory and wound healing properties, which increases its demand in the medical field.
However, the production of high-purity trypsin, suitable for biopharmaceutical applications, requires complex purification processes. Ensuring the enzyme’s purity and activity involves multiple steps, including filtration, chromatography, and rigorous quality control testing, which add to the overall production costs. Thus, the high production costs of trypsin are impeding the market's growth.
Based on source, the market is divided into porcine, bovine, and others. In 2023, the bovine segment garnered 58.9% revenue share in the market. Bovine sources are abundant and readily available in many regions around the world. Cattle farming is prevalent in numerous countries, ensuring a stable and consistent supply of bovine-derived raw materials for trypsin production.
On the basis of application, the market is segmented into biotechnology & pharmaceutical industry, food industry, cosmetics & personal care, waste treatment, and others. In 2023, the food industry segment attained 23.4% revenue share in the market. Trypsin is used in meat processing for its proteolytic activity, which helps tenderize meat by breaking down tough connective tissues.
By end-use, the market is divided into research, diagnostics, and industrial use. In 2023, the industrial use segment registered 81% revenue share in the market. Trypsin exhibits broad substrate specificity and can act on various proteins, peptides, and proteinaceous materials.
Free Valuable Insights: Global Trypsin Market size to reach USD 130.1 Million by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 25.4% revenue share in the trypsin market. The Asia-Pacific region is a major food and beverage production hub driven by population growth, urbanization, and changing consumer preferences.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 87.9 Million |
| Market size forecast in 2031 | USD 130.1 Million |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 5.2% from 2024 to 2031 |
| Number of Pages | 225 |
| Number of Tables | 370 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Source, Application, End-use, Region |
| Country scope |
|
| Companies Included | Merck Millipore (Merck KGaA), Novozymes A/S (Novo Holdings A/S), Agilent Technologies, Inc., Thermo Fisher Scientific, Inc. Promega Corporation, Takara Bio Inc. (Takara Holdings Inc.), Sartorius AG, PromoCell GmbH, Geno Technology, Inc. and Bio-Rad Laboratories, Inc. |
By Source
By Application
By End-use
By Geography
This Market size is expected to reach $130.1 million by 2031.
Increasing demand in biopharmaceutical manufacturing are driving the Market in coming years, however, High production costs restraints the growth of the Market.
Merck Millipore (Merck KGaA), Novozymes A/S (Novo Holdings A/S), Agilent Technologies, Inc., Thermo Fisher Scientific, Inc. Promega Corporation, Takara Bio Inc. (Takara Holdings Inc.), Sartorius AG, PromoCell GmbH, Geno Technology, Inc. and Bio-Rad Laboratories, Inc.
The expected CAGR of this Market is 5.2% from 2024 to 2031.
The Biotechnology & Pharmaceutical Industry segment is leading the Market by Application in 2023; thereby, achieving a market value of $62.1 million by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $49.2 million by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 